Next Article in Journal
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
Previous Article in Journal
Tumor Neovascularization and Developments in Therapeutics
Article Menu

Export Article

Open AccessArticle
Cancers 2019, 11(3), 315;

NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion

Department of Microbiology and Immunology, School of Dentistry, Kyungpook National University, Daegu 700-412, Korea
Research Division, MIRCORE, Ann Arbor, MI 48105, USA
Author to whom correspondence should be addressed.
Received: 22 January 2019 / Revised: 28 February 2019 / Accepted: 1 March 2019 / Published: 6 March 2019
Full-Text   |   PDF [4507 KB, uploaded 6 March 2019]   |  
  |   Review Reports


NGFI-A binding protein 2 (NAB2) represses the transcriptional activation of early growth response protein-1 (EGR1), a tumor-suppressor. However, Epidermal Growth Factor (EGF) promotes tumor progression even with significant EGR1 upregulation. The molecular mechanism through which NAB2 is involved in cancer is largely unknown. Therefore, we evaluated how the NAB2-mediated suppression of EGR1 facilitates head and neck squamous cell carcinoma (HNSCC) cancer progression, in association with Sp1, which competes with EGR1 as a transcriptional regulator. The effect of NAB2 on EGR1/SP1 binding to the consensus promoter sequences of MMP2 and MMP9 was evaluated by chromatin immunoprecipitation (ChIP) and promoter luciferase assay. The correlation between EGR1-NAB2 expression and metastatic status was investigated using The Cancer Genome Atlas (TCGA) for HNSCC patients. Our data showed that NAB2 knockdown in FaDu and YD-10B HNSCC cells alleviated EGF-dependent increase of Matrigel invasion. In addition, NAB2 upregulation in EGF-treated FaDu cell diminishes EGR1 transcriptional activity, resulting in the upregulation of Sp1-dependent tumor-promoting genes. TCGA data analysis of 483 HNSCC tumors showed that higher levels of both EGR1 and NAB2 mRNA were significantly associated with metastasis, corresponding to in vitro results. Our data suggest that NAB2 upregulation facilitates EGF-mediated cancer cell invasion through the transactivation of Sp1-dependent tumor-promoting genes. These results provide insight into the paradoxical roles of EGF-EGR1 in cancer progression. View Full-Text
Keywords: head and neck squamous cell carcinoma; epidermal growth factor; NGFI-A binding protein 2; early growth response 1; Sp1; the cancer genome atlas head and neck squamous cell carcinoma; epidermal growth factor; NGFI-A binding protein 2; early growth response 1; Sp1; the cancer genome atlas

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Kim, J.; Kang, S.-M.; Oh, S.Y.; Lee, H.-J.; Lee, I.; Hwang, J.-C.; Hong, S.-H. NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion. Cancers 2019, 11, 315.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top